Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

Circulating Osteopontin and Prediction of Hepatocellular Carcinoma Development in a Large European Population.

Duarte-Salles T, Misra S, Stepien M, Plymoth A, Muller D, Overvad K, Olsen A, Tjønneland A, Baglietto L, Severi G, Boutron-Ruault MC, Turzanski-Fortner R, Kaaks R, Boeing H, Aleksandrova K, Trichopoulou A, Lagiou P, Bamia C, Pala V, Palli D, Mattiello A, Tumino R, Naccarati A, Bueno-de-Mesquita HB, Peeters PH, Weiderpass E, Quirós JR, Agudo A, Sánchez-Cantalejo E, Ardanaz E, Gavrila D, Dorronsoro M, Werner M, Hemmingsson O, Ohlsson B, Sjöberg K, Wareham NJ, Khaw KT, Bradbury KE, Gunter MJ, Cross AJ, Riboli E, Jenab M, Hainaut P, Beretta L.

Cancer Prev Res (Phila). 2016 Sep;9(9):758-65. doi: 10.1158/1940-6207.CAPR-15-0434. Epub 2016 Jun 23.

2.

Diagnostic and Prognostic Roles of Serum Osteopontin and Osteopontin Promoter Polymorphisms in Hepatitis B-related Hepatocellular Carcinoma.

Chimparlee N, Chuaypen N, Khlaiphuengsin A, Pinjaroen N, Payungporn S, Poovorawan Y, Tangkijvanich P.

Asian Pac J Cancer Prev. 2015;16(16):7211-7.

3.

Significance of plasma osteopontin in diagnosis of hepatitis C virus-related hepatocellular carcinoma.

Nabih MI, Aref WM, Fathy MM.

Arab J Gastroenterol. 2014 Sep-Dec;15(3-4):103-7. doi: 10.1016/j.ajg.2014.08.002. Epub 2014 Sep 22.

PMID:
25249230
4.

Evaluation of Osteopontin as a Biomarker in Hepatocellular Carcinomas in Egyptian Patients with Chronic HCV Cirrhosis

Abdel-Hafiz SM, Hamdy HE, Khorshed FM, Aboushousha TS, Safwat G, Saber MA, Seleem M, Soliman AH.

Asian Pac J Cancer Prev. 2018 Apr 25;19(4):1021-1027.

5.

Osteopontin and latent-TGF β binding-protein 2 as potential diagnostic markers for HBV-related hepatocellular carcinoma.

da Costa AN, Plymoth A, Santos-Silva D, Ortiz-Cuaran S, Camey S, Guilloreau P, Sangrajrang S, Khuhaprema T, Mendy M, Lesi OA, Chang HK, Oh JK, Lee DH, Shin HR, Kirk GD, Merle P, Beretta L, Hainaut P.

Int J Cancer. 2015 Jan 1;136(1):172-81. doi: 10.1002/ijc.28953. Epub 2014 May 15.

6.

Diagnostic Performance of Alpha-Fetoprotein, Protein Induced by Vitamin K Absence, Osteopontin, Dickkopf-1 and Its Combinations for Hepatocellular Carcinoma.

Jang ES, Jeong SH, Kim JW, Choi YS, Leissner P, Brechot C.

PLoS One. 2016 Mar 17;11(3):e0151069. doi: 10.1371/journal.pone.0151069. eCollection 2016.

7.

Identification of osteopontin as a novel marker for early hepatocellular carcinoma.

Shang S, Plymoth A, Ge S, Feng Z, Rosen HR, Sangrajrang S, Hainaut P, Marrero JA, Beretta L.

Hepatology. 2012 Feb;55(2):483-90. doi: 10.1002/hep.24703. Epub 2011 Dec 19.

8.

Diagnostic values of alpha-fetoprotein, dickkopf-1, and osteopontin for hepatocellular carcinoma.

Ge T, Shen Q, Wang N, Zhang Y, Ge Z, Chu W, Lv X, Zhao F, Zhao W, Fan J, Qin W.

Med Oncol. 2015 Mar;32(3):59. doi: 10.1007/s12032-014-0367-z. Epub 2015 Feb 6.

PMID:
25652109
9.

Plasma osteopontin is a biomarker for the severity of alcoholic liver cirrhosis, not for hepatocellular carcinoma screening.

Simão A, Madaleno J, Silva N, Rodrigues F, Caseiro P, Costa JN, Carvalho A.

BMC Gastroenterol. 2015 Jun 30;15:73. doi: 10.1186/s12876-015-0307-1.

10.

Latent transforming growth factor-beta binding protein-1 in circulating plasma as a novel biomarker for early detection of hepatocellular carcinoma.

Cao B, Yang L, Rong W, Feng L, Han N, Zhang K, Cheng S, Wu J, Xiao T, Gao Y.

Int J Clin Exp Pathol. 2015 Dec 1;8(12):16046-54. eCollection 2015.

11.

Diagnostic significance of plasma osteopontin in hepatitis C virus-related hepatocellular carcinoma.

Abu El Makarem MA, Abdel-Aleem A, Ali A, Saber R, Shatat M, Rahem DA, Sayed D.

Ann Hepatol. 2011 Jul-Sep;10(3):296-305.

12.

Comparison osteopontin vs AFP for the diagnosis of HCC: a meta-analysis.

Wan HG, Xu H, Gu YM, Wang H, Xu W, Zu MH.

Clin Res Hepatol Gastroenterol. 2014 Dec;38(6):706-14. doi: 10.1016/j.clinre.2014.06.008. Epub 2014 Jul 14.

PMID:
25034355
13.

Midkine Increases Diagnostic Yield in AFP Negative and NASH-Related Hepatocellular Carcinoma.

Vongsuvanh R, van der Poorten D, Iseli T, Strasser SI, McCaughan GW, George J.

PLoS One. 2016 May 24;11(5):e0155800. doi: 10.1371/journal.pone.0155800. eCollection 2016.

14.

Diagnostic accuracy of osteopontin plus alpha-fetoprotein in the hepatocellular carcinoma: A meta-analysis.

Li J, Chen X, Dai M, Huang S, Chen J, Dai S.

Clin Res Hepatol Gastroenterol. 2017 Oct;41(5):543-553. doi: 10.1016/j.clinre.2017.01.010. Epub 2017 Mar 11.

PMID:
28291627
15.

Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma.

Marrero JA, Feng Z, Wang Y, Nguyen MH, Befeler AS, Roberts LR, Reddy KR, Harnois D, Llovet JM, Normolle D, Dalhgren J, Chia D, Lok AS, Wagner PD, Srivastava S, Schwartz M.

Gastroenterology. 2009 Jul;137(1):110-8. doi: 10.1053/j.gastro.2009.04.005. Epub 2009 Apr 9.

16.

Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: A mathematical model.

Zekri AR, Youssef AS, Bakr YM, Gabr RM, Ahmed OS, Elberry MH, Mayla AM, Abouelhoda M, Bahnassy AA.

World J Gastroenterol. 2016 Apr 28;22(16):4168-82. doi: 10.3748/wjg.v22.i16.4168.

17.

Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP.

Choi JY, Jung SW, Kim HY, Kim M, Kim Y, Kim DG, Oh EJ.

World J Gastroenterol. 2013 Jan 21;19(3):339-46. doi: 10.3748/wjg.v19.i3.339.

18.

Elevated plasma osteopontin levels in patients with hepatocellular carcinoma.

Kim J, Ki SS, Lee SD, Han CJ, Kim YC, Park SH, Cho SY, Hong YJ, Park HY, Lee M, Jung HH, Lee KH, Jeong SH.

Am J Gastroenterol. 2006 Sep;101(9):2051-9. Epub 2006 Jul 18.

PMID:
16848813
19.

Hepatocellular carcinoma risk prediction model for the general population: the predictive power of transaminases.

Wen CP, Lin J, Yang YC, Tsai MK, Tsao CK, Etzel C, Huang M, Hsu CY, Ye Y, Mishra L, Hawk E, Wu X.

J Natl Cancer Inst. 2012 Oct 17;104(20):1599-611. doi: 10.1093/jnci/djs372.

20.

Annexin A2 is a discriminative serological candidate in early hepatocellular carcinoma.

Sun Y, Gao G, Cai J, Wang Y, Qu X, He L, Liu F, Zhang Y, Lin K, Ma S, Yang X, Qian X, Zhao X.

Carcinogenesis. 2013 Mar;34(3):595-604. doi: 10.1093/carcin/bgs372. Epub 2012 Nov 27.

Supplemental Content

Support Center